Quality Gap in Long-Stay Antipsychotic Quality Measure Performance Widens Over the Pandemic, Reversing Past Gains
| Autor: | Jonathan D. Winter MD, Stephen Petterson PhD, Danya M. Qato PharmD, MPH, PhD, J. William Kerns MD, Roy T. Sabo PhD, Katherine M. Winter CFNP, Nicole Brandt PharmD, MBA, Linda Wastila BSPharm, MSPH, PhD, YoonKyung Chung PhD, Adam Funk BS, Craig Ewasiuk JD, PhD, Rebecca Etz PhD, Alex H. Krist MD, MPH |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: | |
| Zdroj: | Gerontology and Geriatric Medicine, Vol 10 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2333-7214 23337214 |
| DOI: | 10.1177/23337214241262914 |
| Popis: | The Centers for Medicare & Medicaid Services (CMS) grades nursing home performance in antipsychotic prescribing quarterly, publishing findings as a quality measure. While scores have improved since 2011, marked performance variation between facilities persists. To assess quality gap changes between best- and worst-performing deciles, we compared quarterly prescribing changes between these groups pre-pandemic (April 2011 to March 2020) and during the pandemic (April 2020 to March 2022). Antipsychotic quality measure scores, improving pre-pandemic, deteriorated during the pandemic. The pre-pandemic quality gap between the best- and worst-performing deciles narrowed as the worst-performing decile improved faster than the best-performing decile. During the pandemic, the quality gap widened as the worst-performing decile relapsed more than the best-performing decile ( p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|